Joanna Kałafut

725 total citations · 1 hit paper
27 papers, 498 citations indexed

About

Joanna Kałafut is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Joanna Kałafut has authored 27 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Genetics. Recurrent topics in Joanna Kałafut's work include Epigenetics and DNA Methylation (6 papers), Developmental Biology and Gene Regulation (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Joanna Kałafut is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Developmental Biology and Gene Regulation (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Joanna Kałafut collaborates with scholars based in Poland, Finland and Netherlands. Joanna Kałafut's co-authors include Alicja Przybyszewska-Podstawka, Adolfo Rivero‐Müller, Andrzej Stepulak, Anna Wawruszak, Paulina Miziak, Marta Hałasa, Michał Kiełbus, Matthias Nees, Arkadiusz Czerwonka and Karolina Okła and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Joanna Kałafut

26 papers receiving 495 citations

Hit Papers

Estrogen Receptor Signaling in Breast Cancer 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanna Kałafut Poland 11 329 110 109 44 35 27 498
Alicja Przybyszewska-Podstawka Poland 10 281 0.9× 105 1.0× 90 0.8× 35 0.8× 34 1.0× 17 408
Chul-Ho Jeong South Korea 9 546 1.7× 72 0.7× 133 1.2× 27 0.6× 46 1.3× 12 652
Marc E. Bracke Belgium 5 286 0.9× 58 0.5× 114 1.0× 33 0.8× 28 0.8× 5 460
Wenping Zhou China 12 310 0.9× 99 0.9× 66 0.6× 12 0.3× 21 0.6× 18 468
Toshiaki Kogame Japan 12 469 1.4× 74 0.7× 169 1.6× 39 0.9× 41 1.2× 31 621
Olga Surova Sweden 11 404 1.2× 163 1.5× 118 1.1× 21 0.5× 20 0.6× 17 564
Anya Alayev United States 12 378 1.1× 94 0.9× 127 1.2× 14 0.3× 106 3.0× 17 627
José Luís Oliva Spain 15 425 1.3× 95 0.9× 101 0.9× 18 0.4× 29 0.8× 23 596
Sathyen A. Prabhu United States 9 321 1.0× 69 0.6× 94 0.9× 27 0.6× 20 0.6× 12 454

Countries citing papers authored by Joanna Kałafut

Since Specialization
Citations

This map shows the geographic impact of Joanna Kałafut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Kałafut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Kałafut more than expected).

Fields of papers citing papers by Joanna Kałafut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Kałafut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Kałafut. The network helps show where Joanna Kałafut may publish in the future.

Co-authorship network of co-authors of Joanna Kałafut

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Kałafut. A scholar is included among the top collaborators of Joanna Kałafut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Kałafut. Joanna Kałafut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kałafut, Joanna, Krystyna Kowalczuk, Arkadiusz Surażyński, et al.. (2025). MM-129 Counteracts 5-Fluorouracil-Induced Cellular Senescence in Colon Cancer via SIRT1/STAT3 Signaling Pathway. Cells. 14(19). 1498–1498.
2.
Hałasa, Marta, Anna Wawruszak, Klaudia Brodaczewska, et al.. (2025). Loss of Sirtuin 7 impairs cell motility and proliferation and enhances S-phase cell arrest after 5-fluorouracil treatment in head and neck cancer. Scientific Reports. 15(1). 2123–2123. 1 indexed citations
3.
Czerwonka, Arkadiusz, Joanna Kałafut, & Matthias Nees. (2023). Modulation of Notch Signaling by Small-Molecular Compounds and Its Potential in Anticancer Studies. Cancers. 15(18). 4563–4563. 7 indexed citations
4.
Kałafut, Joanna, Arkadiusz Czerwonka, Alicja Przybyszewska-Podstawka, et al.. (2023). Regulation of Notch1 Signalling by Long Non-Coding RNAs in Cancers and Other Health Disorders. International Journal of Molecular Sciences. 24(16). 12579–12579. 3 indexed citations
5.
Miziak, Paulina, Ewa Błaszczak, Alicja Przybyszewska-Podstawka, et al.. (2023). Estrogen Receptor Signaling in Breast Cancer. Cancers. 15(19). 4689–4689. 76 indexed citations breakdown →
6.
Przybyszewska-Podstawka, Alicja, et al.. (2023). Synthetic circuits based on split Cas9 to detect cellular events. Scientific Reports. 13(1). 14988–14988. 3 indexed citations
7.
Hermanowicz, Justyna Magdalena, Robert Czarnomysy, Arkadiusz Surażyński, et al.. (2023). Assessment of an Anticancer Effect of the Simultaneous Administration of MM-129 and Indoximod in the Colorectal Cancer Model. Cancers. 16(1). 122–122. 2 indexed citations
8.
Czerwonka, Arkadiusz, Joanna Kałafut, Shaoxia Wang, et al.. (2023). Evaluation of the anticancer activity of RIN-1, a Notch signaling modulator, in head and neck squamous cell carcinoma. Scientific Reports. 13(1). 13700–13700. 4 indexed citations
9.
Kałafut, Joanna, et al.. (2022). Optogenetic control of NOTCH1 signaling. Cell Communication and Signaling. 20(1). 67–67. 10 indexed citations
10.
Misiorek, Julia O., Alicja Przybyszewska-Podstawka, Joanna Kałafut, et al.. (2021). Context Matters: NOTCH Signatures and Pathway in Cancer Progression and Metastasis. Cells. 10(1). 94–94. 56 indexed citations
11.
Kałafut, Joanna, Arkadiusz Czerwonka, Alicja Przybyszewska-Podstawka, et al.. (2021). Shooting at Moving and Hidden Targets—Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas. Cancers. 13(24). 6219–6219. 23 indexed citations
12.
Tylżanowski, Przemko, Jarogniew J. Łuszczki, Joanna Kałafut, et al.. (2021). Differential molecular response of larynx cancer cell lines to combined VPA/CDDP treatment.. PubMed. 11(6). 2821–2837. 5 indexed citations
13.
Kałafut, Joanna, et al.. (2020). A novel bioassay for quantification of surface Cannabinoid receptor 1 expression. Scientific Reports. 10(1). 18191–18191. 3 indexed citations
15.
Wawruszak, Anna, Jarogniew J. Łuszczki, Joanna Kałafut, et al.. (2019). Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis. International Journal of Molecular Sciences. 20(15). 3663–3663. 17 indexed citations
16.
Wawruszak, Anna, Joanna Kałafut, Estera Okoń, et al.. (2019). Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells. Cancers. 11(2). 148–148. 85 indexed citations
17.
Kiełbus, Michał, et al.. (2019). Genetically Engineered Lung Cancer Cells for Analyzing Epithelial–Mesenchymal Transition. Cells. 8(12). 1644–1644. 6 indexed citations
18.
Hałasa, Marta, Anna Wawruszak, Alicja Przybyszewska-Podstawka, et al.. (2019). H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy. Cells. 8(5). 485–485. 48 indexed citations
19.
Kiełbus, Michał, et al.. (2018). Optogenetics in cancer drug discovery. Expert Opinion on Drug Discovery. 13(5). 459–472. 12 indexed citations
20.
Kałafut, Joanna, et al.. (2018). FSHR Trans-Activation and Oligomerization. Frontiers in Endocrinology. 9. 760–760. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026